Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001662244

SEC filings (opens in a new tab)

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Cyteir Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of CYT: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	39	41	+2
Shares	16.0M	16.3M	+289.8K (+1.8%)
Value	$41.7M	$46.3M	+$4.67M (+11.2%)

New holders (11)

Institutions that held Cyteir Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CYT in Q3 2023
Institution	Shares	Value	% of portfolio
VR Advisory Services Ltd	1,072,968	$3.05M	1.08%
Gabelli Funds LLC	442,638	$1.26M	0.01%
Gabelli & Co Investment Advisers, Inc.	416,200	$1.18M	0.19%
Walleye Capital LLC	353,916	$1.01M	0.01%
Bulldog Investors, LLP	200,000	$568.0K	0.20%
Alta Fundamental Advisers LLC	117,346	$333.3K	0.19%
Virtu Financial LLC	80,428	$228.0K	0.02%
Squarepoint Ops LLC	50,878	$144.5K	0.00%
Wittenberg Investment Management, Inc.	28,588	$81.2K	0.03%
Wolverine Asset Management LLC	570	$1.62K	0.00%
Qube Research & Technologies Ltd	4	$11	0.00%

Sold out (9)

Institutions that held Cyteir Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CYT in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Western Standard LLC	524,050	$1.36M
Evercore Wealth Management, LLC	146,676	$381.4K
Two Sigma Advisers, LP	25,900	$67.3K
Dimensional Fund Advisors LP	21,064	$54.8K
Millennium Management LLC	20,494	$53.3K
UBS Group AG	5,267	$13.7K
FNY Investment Advisers, LLC	5,297	$13.0K
Royal Bank of Canada	888	$2.00K
Federated Hermes, Inc.	208	$541